Contact:The Ruth GroupTram Bui / Lee Roth(646) 536-7035 / email@example.com@theruthgroup.com
See the stocks that have performed the worst for 19 billionaires who made their money investing.
Enzymotec (ENZY) plunged more than 30% to a one-year low of $13.60 on Wednesday after the company reported mixed first-quarter results.
By Alex Gavrish, Etalon Investment Research; author of "Wall Street Back To Basics" After a successful IPO in 2013, Enzymotec Ltd (NASDAQ:ENZY) recently completed a secondary public offering. Joh...